JP2011507862A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507862A5 JP2011507862A5 JP2010539519A JP2010539519A JP2011507862A5 JP 2011507862 A5 JP2011507862 A5 JP 2011507862A5 JP 2010539519 A JP2010539519 A JP 2010539519A JP 2010539519 A JP2010539519 A JP 2010539519A JP 2011507862 A5 JP2011507862 A5 JP 2011507862A5
- Authority
- JP
- Japan
- Prior art keywords
- connexin
- composition
- polynucleotide
- scar
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US887707P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/014028 WO2009085277A2 (en) | 2007-12-21 | 2008-12-22 | Treatment of abnormal or excessive scars |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014248308A Division JP2015057431A (ja) | 2007-12-21 | 2014-12-08 | 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507862A JP2011507862A (ja) | 2011-03-10 |
| JP2011507862A5 true JP2011507862A5 (https=) | 2013-04-25 |
Family
ID=40824960
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539519A Pending JP2011507862A (ja) | 2007-12-21 | 2008-12-22 | 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用 |
| JP2014248308A Pending JP2015057431A (ja) | 2007-12-21 | 2014-12-08 | 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014248308A Pending JP2015057431A (ja) | 2007-12-21 | 2014-12-08 | 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110130710A1 (https=) |
| EP (1) | EP2252690A2 (https=) |
| JP (2) | JP2011507862A (https=) |
| AU (1) | AU2008343758A1 (https=) |
| CA (1) | CA2710388A1 (https=) |
| WO (1) | WO2009085277A2 (https=) |
| ZA (1) | ZA201005223B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1959981T3 (da) | 2005-02-03 | 2020-01-27 | Coda Therapeutics Ltd | Anti-connexin 43 forbindelser til behandling af kroniske sår |
| EP2245158A2 (en) * | 2007-12-11 | 2010-11-03 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
| US8975237B2 (en) | 2007-12-21 | 2015-03-10 | Coda Therapeutics, Inc. | Treatment of fibrotic conditions |
| CA2866115C (en) | 2012-03-01 | 2020-03-24 | Firststring Research, Inc. | Topical gels containing alpha connexin c-terminal (act) peptides |
| US10576037B2 (en) * | 2012-03-14 | 2020-03-03 | MAM Holdings of West Florida, L.L.C. | Compositions comprising placental collagen for use in wound healing |
| CA2868534A1 (en) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions and treatments based on cadherin modulation |
| US20140072613A1 (en) * | 2012-09-10 | 2014-03-13 | Cynthia Lander | Compositions and Methods for Treating Cutaneous Scarring |
| US10465188B2 (en) | 2014-08-22 | 2019-11-05 | Auckland Uniservices Limited | Channel modulators |
| EP3265493B1 (en) | 2015-03-02 | 2024-01-10 | 180 Therapeutics LP | Method of treating a localized fibrotic disorder using an il-33 antagonist |
| WO2016149194A1 (en) | 2015-03-13 | 2016-09-22 | MAM Holdings of West Florida, L.L.C. | Collagen compositions and uses for biomaterial implants |
| CN111201247A (zh) | 2017-04-28 | 2020-05-26 | 奥克兰联合服务有限公司 | 治疗方法和新颖构建体 |
| US11273175B2 (en) * | 2017-06-26 | 2022-03-15 | Next Science IP Holdings Pty Ltd | Method for treating fibrillar collagenous conditions |
| WO2019152110A1 (en) * | 2018-01-31 | 2019-08-08 | Kci Usa, Inc. | Antimicrobial composition, dressing, dressing components, and method |
| JP2023546757A (ja) | 2020-10-22 | 2023-11-07 | シークエル・バイオ・インコーポレイテッド | ペプチド製剤および眼科におけるその使用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861757A (en) * | 1986-11-14 | 1989-08-29 | Institute Of Molecular Biology | Wound healing and bone regeneration using PDGF and IGF-I |
| US5004810A (en) * | 1988-09-30 | 1991-04-02 | Schering Corporation | Antiviral oligomers |
| US5166195A (en) * | 1990-05-11 | 1992-11-24 | Isis Pharmaceuticals, Inc. | Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides |
| GB9206861D0 (en) * | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
| US6566339B1 (en) * | 1995-08-04 | 2003-05-20 | Renovo Limited | Pharmaceutical composition |
| GB2304047A (en) * | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
| PT871730E (pt) * | 1995-10-11 | 2004-11-30 | Chiron Corp | Combinacao de pdgf, kgf, igf e igfbp para cicatrizacao de ferimentos |
| IT1294967B1 (it) * | 1996-10-09 | 1999-04-23 | Ist Farmacoterapico It Spa | Composizione immunogenica da tlp |
| WO1998021358A1 (en) * | 1996-11-15 | 1998-05-22 | University Of Massachusetts | Huntingtin-related therapeutics and bioassay |
| GB9702943D0 (en) * | 1997-02-13 | 1997-04-02 | Univ Manchester | Wound healing |
| US5965618A (en) * | 1997-11-17 | 1999-10-12 | Perricone; Nicholas V. | Treatment of scar tissue using lipoic acid |
| US6855505B2 (en) * | 1998-06-26 | 2005-02-15 | Renovo Limited | Method for quantifying TGF-β |
| DK1146908T3 (da) * | 1999-01-27 | 2005-10-10 | Becker David Dr | Formuleringer omfattende antisense-nukleotider mod connexiner |
| GB9903598D0 (en) * | 1999-02-18 | 1999-04-07 | Univ Manchester | Connective tissue healing |
| US7229822B1 (en) * | 2000-02-29 | 2007-06-12 | Univ Columbia | Melanoma differentation associated gene-5 and vectors and cells containing same |
| US7186802B2 (en) * | 2000-08-15 | 2007-03-06 | Immunex Corporation | Claudin polypeptides |
| US20050119211A1 (en) * | 2001-05-18 | 2005-06-02 | Sirna Therapeutics, Inc. | RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA) |
| US7767717B2 (en) * | 2003-06-09 | 2010-08-03 | Ascend Therapeutics, Inc. | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |
| CA3059497A1 (en) * | 2003-12-03 | 2005-06-16 | Ocunexus Therapeutics, Inc. | Antisense compounds targeted to connexins and methods of use thereof |
| JP5097891B2 (ja) * | 2005-09-20 | 2012-12-12 | 株式会社ポーラファルマ | 皮膚外用剤 |
| EP2091557A2 (en) * | 2006-11-15 | 2009-08-26 | Coda Therapeutics, INC. | Improved methods and compositions for wound healing |
| EP2342340A1 (en) * | 2008-09-22 | 2011-07-13 | Rxi Pharmaceuticals Corporation | Rna interference in skin indications |
-
2008
- 2008-12-22 AU AU2008343758A patent/AU2008343758A1/en not_active Abandoned
- 2008-12-22 US US12/809,916 patent/US20110130710A1/en not_active Abandoned
- 2008-12-22 WO PCT/US2008/014028 patent/WO2009085277A2/en not_active Ceased
- 2008-12-22 CA CA2710388A patent/CA2710388A1/en not_active Abandoned
- 2008-12-22 JP JP2010539519A patent/JP2011507862A/ja active Pending
- 2008-12-22 EP EP08868684A patent/EP2252690A2/en not_active Withdrawn
-
2010
- 2010-07-21 ZA ZA2010/05223A patent/ZA201005223B/en unknown
-
2014
- 2014-12-08 JP JP2014248308A patent/JP2015057431A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507862A5 (https=) | ||
| Ouyang et al. | Targeted delivery of hesperetin to cartilage attenuates osteoarthritis by bimodal imaging with Gd2 (CO3) 3@ PDA nanoparticles via TLR-2/NF-κB/Akt signaling | |
| JP5736397B2 (ja) | コネキシンに対するアンチセンスヌクレオチドを含む配合物 | |
| EP2359828A1 (en) | HDAC inhibitors and hormone targeted drugs for the treatment of cancer | |
| US20110130710A1 (en) | Treatment of abnormal or excessive scars | |
| JP2015518712A (ja) | Ｍｅｃｐ２発現を調節するための組成物及び方法 | |
| JP2015523855A (ja) | Ａｐｏａ１及びａｂｃａ１発現を調節するための組成物及び方法 | |
| WO2011140285A2 (en) | Combinations of tgfbeta and cox-2 inhibitors and methods for their therapeutic application | |
| JP2011507860A (ja) | 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用 | |
| KR20130095835A (ko) | 여드름 및 기타 질환 치료용 비스파틴 치료제 | |
| JP2008510705A (ja) | Ｐｄｅ５阻害剤組成物及び心臓疾患を治療する方法 | |
| EP2956148B1 (en) | Compositions and methods for pain relief without numbness | |
| JP2011507859A5 (https=) | ||
| JP2023021241A (ja) | Ｍｅｋ阻害剤治療によって惹起される皮膚反応を治療するｂｒａｆ阻害剤の使用 | |
| Ali et al. | Comparison of 5 fluorouracil and triamcinolone acetonide intralesional injection in the management of keloid | |
| CN104736709A (zh) | 基于钙粘蛋白调节的组合物和治疗 | |
| Song et al. | Targeting a key pro-fibrotic factor S100A4 in cartilage to alleviate osteoarthritis progression and pain | |
| Feldner et al. | Experimental hypertension triggers varicosis‐like maladaptive venous remodeling through activator protein‐1 | |
| Lee et al. | Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts | |
| EP3107551B1 (en) | Compositions comprising bicarbonate and calcium salts for pain relief without numbness | |
| ES2748609T3 (es) | Agonista de receptor beta-2-adrenérgico para igualar el color de las cicatrices de la piel | |
| CN114404592A (zh) | Tet2作为靶标在治疗缺血性血管疾病中的应用 | |
| Huang et al. | ZC3H15 suppression ameliorates bone cancer pain through inhibiting neuronal oxidative stress and microglial inflammation | |
| KR20260051038A (ko) | 조직의 성장 및 복구를 촉진하는 제품의 제조에서의 2가 금속 락테이트의 용도 | |
| US20190282600A1 (en) | Combination therapies targeting tert dependency for cancer therapy |